PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMAB vs. SCHG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between GMAB and SCHG is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

GMAB vs. SCHG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genmab A/S (GMAB) and Schwab U.S. Large-Cap Growth ETF (SCHG). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-18.69%
14.67%
GMAB
SCHG

Key characteristics

Sharpe Ratio

GMAB:

-0.72

SCHG:

1.63

Sortino Ratio

GMAB:

-0.89

SCHG:

2.18

Omega Ratio

GMAB:

0.89

SCHG:

1.29

Calmar Ratio

GMAB:

-0.36

SCHG:

2.36

Martin Ratio

GMAB:

-0.99

SCHG:

8.91

Ulcer Index

GMAB:

22.30%

SCHG:

3.27%

Daily Std Dev

GMAB:

30.76%

SCHG:

17.93%

Max Drawdown

GMAB:

-84.20%

SCHG:

-34.59%

Current Drawdown

GMAB:

-54.91%

SCHG:

-0.65%

Returns By Period

In the year-to-date period, GMAB achieves a 5.27% return, which is significantly higher than SCHG's 3.73% return. Over the past 10 years, GMAB has underperformed SCHG with an annualized return of 11.68%, while SCHG has yielded a comparatively higher 16.51% annualized return.


GMAB

YTD

5.27%

1M

5.62%

6M

-20.08%

1Y

-24.11%

5Y*

-2.73%

10Y*

11.68%

SCHG

YTD

3.73%

1M

2.19%

6M

13.00%

1Y

31.53%

5Y*

18.91%

10Y*

16.51%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GMAB vs. SCHG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMAB
The Risk-Adjusted Performance Rank of GMAB is 1717
Overall Rank
The Sharpe Ratio Rank of GMAB is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of GMAB is 1212
Sortino Ratio Rank
The Omega Ratio Rank of GMAB is 1313
Omega Ratio Rank
The Calmar Ratio Rank of GMAB is 2424
Calmar Ratio Rank
The Martin Ratio Rank of GMAB is 2323
Martin Ratio Rank

SCHG
The Risk-Adjusted Performance Rank of SCHG is 6767
Overall Rank
The Sharpe Ratio Rank of SCHG is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of SCHG is 6363
Sortino Ratio Rank
The Omega Ratio Rank of SCHG is 6666
Omega Ratio Rank
The Calmar Ratio Rank of SCHG is 7070
Calmar Ratio Rank
The Martin Ratio Rank of SCHG is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMAB vs. SCHG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Genmab A/S (GMAB) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GMAB, currently valued at -0.72, compared to the broader market-2.000.002.00-0.721.63
The chart of Sortino ratio for GMAB, currently valued at -0.89, compared to the broader market-4.00-2.000.002.004.006.00-0.892.18
The chart of Omega ratio for GMAB, currently valued at 0.89, compared to the broader market0.501.001.502.000.891.29
The chart of Calmar ratio for GMAB, currently valued at -0.36, compared to the broader market0.002.004.006.00-0.362.36
The chart of Martin ratio for GMAB, currently valued at -0.99, compared to the broader market0.0010.0020.0030.00-0.998.91
GMAB
SCHG

The current GMAB Sharpe Ratio is -0.72, which is lower than the SCHG Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of GMAB and SCHG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.72
1.63
GMAB
SCHG

Dividends

GMAB vs. SCHG - Dividend Comparison

GMAB has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.38%.


TTM20242023202220212020201920182017201620152014
GMAB
Genmab A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SCHG
Schwab U.S. Large-Cap Growth ETF
0.38%0.40%0.46%0.55%0.42%0.52%0.82%1.27%1.01%1.04%1.22%1.09%

Drawdowns

GMAB vs. SCHG - Drawdown Comparison

The maximum GMAB drawdown since its inception was -84.20%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for GMAB and SCHG. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-54.91%
-0.65%
GMAB
SCHG

Volatility

GMAB vs. SCHG - Volatility Comparison

Genmab A/S (GMAB) has a higher volatility of 12.99% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 4.99%. This indicates that GMAB's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%SeptemberOctoberNovemberDecember2025February
12.99%
4.99%
GMAB
SCHG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab